NO20024011L - Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret - Google Patents

Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret

Info

Publication number
NO20024011L
NO20024011L NO20024011A NO20024011A NO20024011L NO 20024011 L NO20024011 L NO 20024011L NO 20024011 A NO20024011 A NO 20024011A NO 20024011 A NO20024011 A NO 20024011A NO 20024011 L NO20024011 L NO 20024011L
Authority
NO
Norway
Prior art keywords
prebiotic
aid
improve
immune system
enhancing
Prior art date
Application number
NO20024011A
Other languages
English (en)
Other versions
NO20024011D0 (no
Inventor
Ferdinand Haschke
Anne-Lise Carrie
Zdenek Kratky
Harriet Link-Amster
Florence Rochat
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20024011L publication Critical patent/NO20024011L/no
Publication of NO20024011D0 publication Critical patent/NO20024011D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)

Abstract

Et prebiotikum for forbedring av en immunreaksjon, en ernæringssammensetning for forbedring av en immunreaksjon; anvendelse av et prebiotikum ved fremstilling av et legemiddel eller ernæringssammensetning for forbedring av en immunreaksjon; anvendelse av et prebiotikum ved fremstilling av et legemiddel eller ernæringssammensetning for forebygging eller behandling av meslinger; en fremgangsmåte for å forbedre en immunreaksjon som innbefatter administrering av en virksom mengde av et prebiotikum; og en fremgangsmåte for forebygging eller behandling av meslinger som innbefatter administrering av en virksom mengde av et prebiotikum. I foretrukne utførelsesformer innbefatter prebiotikumet et fruktooligosakkarid.
NO20024011A 2000-03-01 2002-08-22 Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret NO20024011D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (2)

Publication Number Publication Date
NO20024011L true NO20024011L (no) 2002-08-22
NO20024011D0 NO20024011D0 (no) 2002-08-22

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024011A NO20024011D0 (no) 2000-03-01 2002-08-22 Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret

Country Status (22)

Country Link
US (2) US20030040492A1 (no)
EP (1) EP1261355B1 (no)
JP (1) JP4838477B2 (no)
KR (1) KR20020081375A (no)
CN (1) CN1243551C (no)
AR (1) AR027968A1 (no)
AT (1) ATE283697T1 (no)
AU (2) AU3174601A (no)
BR (1) BR0108828A (no)
CA (1) CA2400969C (no)
DE (1) DE60107544T2 (no)
ES (1) ES2232591T3 (no)
HK (1) HK1051650A1 (no)
HU (1) HUP0204546A3 (no)
IL (1) IL151280A0 (no)
MX (1) MXPA02008447A (no)
NO (1) NO20024011D0 (no)
PL (1) PL365136A1 (no)
PT (1) PT1261355E (no)
UA (1) UA73763C2 (no)
WO (1) WO2001064225A1 (no)
ZA (1) ZA200207849B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CA2530437C (en) * 2003-06-23 2011-11-15 Nestec S.A. Nutritional formula for optimal gut barrier function
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
EP2073643A2 (en) * 2006-10-18 2009-07-01 DSMIP Assets B.V. Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (en) * 2007-08-24 2010-05-26 Barry Callebaut AG Process and confectionery product produced thereby
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
PT2285387E (pt) 2008-06-13 2016-02-09 Nutricia Nv Nutrição para a prevenção de infeções
EP2293802A4 (en) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
MY164674A (en) 2009-07-15 2018-01-30 Nutricia Nv Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
WO2011008086A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
CA2777941C (en) * 2009-11-12 2018-08-14 Nestec S.A. Nutritional composition for promoting gut microbiota balance and health
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US20150086587A1 (en) * 2012-03-28 2015-03-26 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
JP6637587B2 (ja) * 2015-08-04 2020-01-29 ズートツッカー アーゲー 副鼻腔炎に対するイヌリンの予防的使用
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
MA50087A (fr) * 2017-09-08 2020-07-15 Evelo Biosciences Inc Vésicules extracellulaires provenant de prevotella
JP7369690B2 (ja) 2017-09-08 2023-10-26 エヴェロ バイオサイエンシズ，インコーポレーテッド 細菌の細胞外小胞
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247071B1 (en) * 1985-10-31 1993-09-22 The Australian National University Immunotherapeutic treatment
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise, S.A. Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
JP2003533438A (ja) 2003-11-11
HUP0204546A2 (en) 2003-05-28
HK1051650A1 (en) 2003-08-15
CN1422158A (zh) 2003-06-04
KR20020081375A (ko) 2002-10-26
BR0108828A (pt) 2002-12-10
HUP0204546A3 (en) 2003-10-28
CA2400969C (en) 2011-04-19
UA73763C2 (en) 2005-09-15
JP4838477B2 (ja) 2011-12-14
DE60107544T2 (de) 2005-12-15
US7101553B2 (en) 2006-09-05
DE60107544D1 (de) 2005-01-05
AU3174601A (en) 2001-09-12
ATE283697T1 (de) 2004-12-15
AR027968A1 (es) 2003-04-16
ZA200207849B (en) 2003-12-30
AU2001231746C1 (en) 2005-10-06
CA2400969A1 (en) 2001-09-07
WO2001064225A1 (en) 2001-09-07
PT1261355E (pt) 2005-02-28
NO20024011D0 (no) 2002-08-22
PL365136A1 (en) 2004-12-27
IL151280A0 (en) 2003-04-10
CN1243551C (zh) 2006-03-01
EP1261355B1 (en) 2004-12-01
AU2001231746B2 (en) 2004-12-23
MXPA02008447A (es) 2002-12-13
EP1261355A1 (en) 2002-12-04
US20030040492A1 (en) 2003-02-27
ES2232591T3 (es) 2005-06-01
US20040191234A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
NO20024011L (no) Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
SG152270A1 (en) Immunemodulating oligosaccharides
DE60220182D1 (de) Alkoholfreies getränkeersatz
WO2005055934A3 (en) Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
NO20072906L (no) Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
NO20023473D0 (no) Sammensetninger for levering av en kortisol antagonist
NO20060498L (no) Metode for a promotere benvekst
NO20045240L (no) Transepikutan administrasjonsform for a behandle restless legs syndromet
CA2408537A1 (en) Treating irritable bowel syndrome or disease
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
DK1196174T3 (da) Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose
BRPI0416088A (pt) composição, sistema, e método de tratar condições tais como calcificação vascular
BR0206087A (pt) Formulação de enxaguamento redutora para uso com ozÈnio no tratamento de cáries dentárias
EP1550443A4 (en) COMPOSITION AGAINST STRESS-BASED DISEASES
AU7941294A (en) Composition for the treatment or prevention of herpes
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
AU4155700A (en) Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
NO982854D0 (no) Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes
BR0113101A (pt) Utilização de um inibidor de lìpases e processo e medicamento oral para tratamento, redução ou prevenção de dispepsia funcional
MY127741A (en) Wash-off vitamin e compositions
BR9507848A (pt) Composição farmcéutica contendo espiramicina eventualmente em associação com o metronizadol
WO2003032895A3 (en) Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer
BR0313046A (pt) Uso de inibidores de quimase para prevenção e/ou tratamento de insuficiência de enxerto arteriovenoso